Subvisible Particle Analysis: Ensuring Quality from Lab Bench to GMP

November 18th 2025 - 16:00pm (CET) / 10:00am (ET)

Subvisible Particle Analysis: Ensuring Quality from Lab Bench to GMP

November 18th 2025 - 16:00pm (CET) / 10:00am (ET)

Addressed Challenges

  • Different regulatory expectations for analytical methods in R&D vs. GMP: workflows, communication, and audit readiness
  • Extensive documentation during experimental planning: a time-consuming but critical element for ensuring successful validation
  • Variability caused by equipment performance and operator differences
  • Uncertainty in measurements leading to considerable misestimation of results when samples undergo dilution.

What You Will Learn

  • Learn about essential regulatory requirements for initiation of a contract testing activities under GMP, like contractual definitions of responsibilities and formal qualification of the GMP laboratory.
  • Understand the differences in quality requirements during the transition of analytical methods from R&D to GMP
  • Learn about regulatory requirements for validating analytical procedures for the quantification of subvisible particles
  • Identify common sources of variability in subvisible particle analysis and explore strategies to mitigate them

Dr. Bodo Brocks

Quality Unit Manager

Dr. Bodo Brocks holds a diploma in Technical Biology from the University of Stuttgart and earned his doctorate in the field of phage display and therapeutic antibodies in a collaboration with Boehringer Ingelheim. From 1999 t0 2021 he has held different positions at the former German biotech flagship MorphoSys AG. As Director of Analytical Development, Head of QC, and Director of QA we was deeply involved in research, clinical development and market launch of therapeutic antibody products. Since October 2021, he has been Head of Quality at Coriolis Pharma and is responsible for the global quality management under R&D and GMP.
Read More >>>

Dr. Sergey Sotnikov

Principal Scientist GMP

Dr. Sergey Sotnikov holds a diploma in Pharmacy from the Medical State University in Moscow (2011) and completed his doctoral studies in Biology at Ludwig Maximilian University of Munich in 2014. Following his PhD, he spent four years as a Senior Scientist at a biotech start-up, where he was responsible for developing new analytical methods for quality control and providing analytical support for production and formulation development programs. Since 2019, Sergey has been working at Coriolis Pharma in the GMP Analytics department, where he has held several roles including Project Manager, Group Leader, and currently Principal Scientist. His work focuses on the implementation and validation of analytical methods, batch release testing, and stability studies. Most recently, he has been involved in the expansion of GMP services at Coriolis Pharma, leading the implementation of new analytical methods and serving as a subject matter expert in QC and GMP-related topics.
Read More >>>

By ticking this box, you agree to the privacy policies of Coriolis Pharma and Livestorm, consenting to receiving communications related to this topic and other products or services within their portfolio

Dark